Loading...
Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain
Treatment with nitisinone (NTBC) has brought about a drastic improvement in the treatment and prognosis of hereditary tyrosinemia type I (HT1). We conducted a retrospective observational multicentric study in Spanish HT1 patients treated with NTBC to assess clinical and biochemical long-term evoluti...
Na minha lista:
| Udgivet i: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer Health
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6775438/ https://ncbi.nlm.nih.gov/pubmed/31574857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000017303 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|